HODGKIN DISEASE
Clinical trials for HODGKIN DISEASE explained in plain language.
Never miss a new study
Get alerted when new HODGKIN DISEASE trials appear
Sign up with your email to follow new studies for HODGKIN DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New lymphoma drug trial halted early
Disease control TerminatedThis study tested a new drug, PF-08046045, in people with advanced lymphomas (cancers of the immune system). The goal was to find a safe dose and check for side effects. The trial was stopped early, and only 22 people took part.
Matched conditions: HODGKIN DISEASE
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated May 26, 2026 05:11 UTC
-
New lymphoma drug enters first human safety tests
Disease control TerminatedThis study tested a new experimental drug called PF-08046044/SGN-35C in 58 adults with advanced lymphomas (Hodgkin, T-cell, or B-cell types) that had not responded to other treatments. The main goal was to check the drug's safety and find the best dose. The study was terminated e…
Matched conditions: HODGKIN DISEASE
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated May 26, 2026 05:03 UTC